How Nutribites Grew 74.5% While Staying Investor-Free

Nutribites makes clean, additive-free nutritional supplements, including magnesium, probiotics, and multivitamins, sold directly to consumers through its own site. Founded by Bnar Falx, the brand tests every formulation with accredited independent laboratories and publishes full detail on ingredients and sourcing. Nutribites is on track for around €8 million in revenue this year, with growth of 74.5% in the first half of 2026 compared with the same period the year before.

A founder's own experience with malnutrition became the company's mission

Bnar Falx has no memory of the malnutrition he experienced as a young child, fleeing Iraq with his family during Saddam Hussein's regime. But it shaped how he thought about food and nutrition for the rest of his life. Years later, researching nutritional deficiencies, he became convinced that many people in the Netherlands were overfed with calories, but underfed in vitamins.

When he looked at the supplement market, he found a category built on opacity.

Supplements without questionable or unnecessary additives were almost impossible to find. The industry also felt like a black box: consumers cannot see or taste the difference in quality, even though the label, ingredients, sourcing and production process can make a world of difference.

Nutribites set out to fix that: clean formulations, carefully selected ingredients, and full transparency about what goes into every product. The standard proved hard to hit. Suppliers said some formulations couldn't be manufactured without certain processing aids, and the brand's first product went through more than twenty-one trial rounds before it met the bar Falx had set.

That perseverance still defines Nutribites today.

Growing without investors meant every order was funded from within

Nutribites scaled without external investors, funding its growth from the business itself. That worked while the company was smaller. In the scale-up phase, the balancing act got harder: Nutribites typically holds about two and a half months of inventory, while repeat production orders carry lead times of around twelve weeks, meaning new stock has to be paid for well before the existing batch has sold through. Supply delays that used to be occasional became more frequent and less predictable. Protecting product availability meant placing larger orders and holding more stock, which tied up more working capital at the point the business most needed to keep moving.

Without additional financing, we would have had to choose between maintaining a larger safety buffer and investing confidently in growth.

Traditional banks were the first option Nutribites tried, and the fit was poor.

The people we spoke with were friendly, but the institutions themselves struggled to accommodate the realities of a fast-growing eCommerce business.

A personal guarantee was a sticking point at every bank Nutribites approached, one that some of their own representatives admitted didn't make much sense for the situation but couldn't work around. Equity was ruled out for a different reason: giving up ownership and voting rights didn't square with a business built to protect its own long-term product decisions.

Speed, simplicity, and transparency without giving up control

Wayflyer reached Nutribites through LinkedIn. Falx and his team still ran their own due diligence before moving forward, checking reviews, funding structure, and terms, and found reassurance in Wayflyer's institutional backing, including its relationship with J.P. Morgan. What decided it, in the end, was the combination of speed, simplicity, and transparency, along with financing that didn't require a personal guarantee.

The capital gave Nutribites room to place larger production orders and build a stronger inventory position without cutting into its safety margin. Revenue grew 74.5% across the first two quarters of 2026 compared with the same period a year earlier, putting the business on track for around €8 million this year.

The funding also supported product development: Nutribites used the additional resources to prove that processing aids suppliers said were required, like stearate and silicon dioxide, could be removed from its tablets without compromising manufacturing. It's now the only company in the Netherlands offering tablets at that dosage without either ingredient.

Falx describes the relationship as a steady source of financial backing rather than a one-time transaction.

We know that when a new opportunity or capital requirement arises, we can reach out, discuss what the business needs and explore the next step together.

That has let Nutribites plan around its own timeline instead of its supply chain's. The company's next goal is to keep scaling while raising the standard of its full product range.

Growth is important, but it will never come at the expense of quality.

Interested in following in Nutribites' footsteps? Wayflyer has funded over 6,000 businesses worldwide with $6 billion worth of working capital, backed by world-leading financial institutions. Apply in minutes and access funds in hours. Start your application today.